Publication Date
8-14-2023
Journal
Cancer Cell
DOI
10.1016/j.ccell.2023.06.009
PMID
37582339
PMCID
PMC10506762
PubMedCentral® Posted Date
8-14-2024
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Humans, Proteogenomics, Proteomics, Genomics, Neoplasms, Gene Expression Profiling, pan-cancer, proteogenomics, data harmonization, multi-omics, open data, CPTAC
Abstract
The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) investigates tumors from a proteogenomic perspective, creating rich multi-omics datasets connecting genomic aberrations to cancer phenotypes. To facilitate pan-cancer investigations, we have generated harmonized genomic, transcriptomic, proteomic, and clinical data for >1000 tumors in 10 cohorts to create a cohesive and powerful dataset for scientific discovery. We outline efforts by the CPTAC pan-cancer working group in data harmonization, data dissemination, and computational resources for aiding biological discoveries. We also discuss challenges for multi-omics data integration and analysis, specifically the unique challenges of working with both nucleotide sequencing and mass spectrometry proteomics data.

- Citations
- Citation Indexes: 25
- Usage
- Downloads: 9
- Abstract Views: 1
- Captures
- Readers: 193
- Mentions
- Blog Mentions: 1
- News Mentions: 23
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Biomedical Informatics Commons, Genetics and Genomics Commons, Medical Genetics Commons, Medical Molecular Biology Commons, Neoplasms Commons, Oncology Commons